Your browser doesn't support javascript.
loading
Synergy between Toxoplasma gondii type I ΔGRA17 immunotherapy and PD-L1 checkpoint inhibition triggers the regression of targeted and distal tumors.
Zhu, Yu-Chao; Elsheikha, Hany M; Wang, Jian-Hua; Fang, Shuai; He, Jun-Jun; Zhu, Xing-Quan; Chen, Jia.
Afiliação
  • Zhu YC; Department of Radiology, The Affiliated Hospital of Medical School of Ningbo University, Ningbo, Zhejiang, China.
  • Elsheikha HM; Immunology Innovation Team, Ningbo University School of Medicine, Ningbo, Zhejiang, China.
  • Wang JH; Faculty of Medicine and Health Sciences, School of Veterinary Medicine and Science, University of Nottingham, Sutton Bonington Campus, Loughborough, UK xingquanzhu1@hotmail.com chenjia@nbu.edu.cn hany.elsheikha@nottingham.ac.uk.
  • Fang S; Department of Radiology, The Affiliated Hospital of Medical School of Ningbo University, Ningbo, Zhejiang, China.
  • He JJ; Immunology Innovation Team, Ningbo University School of Medicine, Ningbo, Zhejiang, China.
  • Zhu XQ; Department of Radiology, The Affiliated Hospital of Medical School of Ningbo University, Ningbo, Zhejiang, China.
  • Chen J; Immunology Innovation Team, Ningbo University School of Medicine, Ningbo, Zhejiang, China.
J Immunother Cancer ; 9(11)2021 11.
Article em En | MEDLINE | ID: mdl-34725213

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Toxoplasma / Inibidores de Checkpoint Imunológico / Imunoterapia Limite: Animals / Female / Humans Idioma: En Revista: J Immunother Cancer Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China País de publicação: Reino Unido

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Toxoplasma / Inibidores de Checkpoint Imunológico / Imunoterapia Limite: Animals / Female / Humans Idioma: En Revista: J Immunother Cancer Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China País de publicação: Reino Unido